Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

Share Price is delayed by 15 minutes
Get Live Data
134.00    0.00 (0.00%)
Bid:
133.00
Ask:
135.00
Spread: 2.00 (1.504%)
Market Cap: £126.23m
TRU Live PriceLast checked at - London Stock Exchange

Intraday Trufin Plc Share Chart

Trading Update

14 Aug 2025 07:00

RNS Number : 2578V
TruFin PLC
14 August 2025
 

14 August 2025

TruFin plc("TruFin" or the "Company" or together with its subsidiaries the "Group")

Trading Update

 

TruFin is pleased to provide a trading update for the six months ended 30 June 2025 ("the Period") ahead of its interim results due in September 2025.

Group revenue for the Period is expected to be approximately £35.5m. This represents growth in excess of 40% over the comparator period (HY24: £25.3m). This strong performance has been primarily driven by continued momentum within Playstack Ltd ("Playstack").

Adjusted EBITDA1 for the Period is expected to be more than £6.7m, representing a year-on-year improvement in excess of 125% (HY24: £2.9m). Group PBT1 for the Period is expected to be more than £4.7m, representing a year-on-year improvement in excess of 670% (HY24: £0.6m). As a result of the Group's performance during the Period, it expects to materially exceed market expectations for the full year.

The second half of the year has started strongly, helped in particular by the full launch of Abiotic Factor at Playstack in July 2025. Playstack's hit ratio - measured by the percentage of games generating a positive return on external development costs - remains outstanding. With a growing back catalogue, strong return on invested capital track record, and impressive pre-launch data from its secured games pipeline, Playstack is well-positioned for 2025 and beyond.

The Company will give further details of its performance across the Group in its forthcoming interim results.

Notes

1 Excluding share-based payments

The information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No.596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. By the publication of this Announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this Announcement on behalf of the Company is Pav Subramaniam.

For further information, please contact:

TruFin plcJames van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

0203 743 134007779 229508

Panmure Liberum Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward Thomas

0203 100 2000

 

 

TruFin plc is the holding company of an operating group comprising three growth-focused technology businesses operating in niche markets: early payment provision, invoice finance and mobile games publishing. The Company was admitted to AIM in February 2018 and trades under the ticker symbol: TRU. More information is available on the Company website: www.TruFin.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFLITTIVLIE
Date   Source Headline
20th Dec 20239:40 amRNSHolding(s) in Company
14th Dec 20237:00 amRNSAppointment of INED to the Board of Oxygen
21st Nov 20237:00 amRNSPlaystack enters into LoI for sale of Interact
9th Nov 20237:00 amRNSOxygen Finance acquisition of bidstats.uk
18th Oct 20234:19 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSSale of Majority Holding in Vertus
29th Sep 20237:00 amRNSHalf-year Report
28th Sep 202312:07 pmRNSResult of AGM
14th Sep 20238:00 amRNSPlaystack releases award-winning game - AK-xolotl
29th Aug 20236:19 pmRNSNotice of AGM
21st Aug 20237:00 amRNSNon-Binding Offer for Vertus
28th Jul 20237:00 amRNSGrant of Share Awards under LTIP
18th Jul 20238:59 amRNSHolding(s) in Company
18th Jul 20238:58 amRNSHolding(s) in Company
18th Jul 20238:55 amRNSHolding(s) in Company
10th Jul 202312:03 pmRNSResult of GM and Result of Placing and Open Offer
23rd Jun 20237:00 amRNSResult of Placing and Notice of General Meeting
22nd Jun 20234:45 pmRNSProposed Placing and Open Offer
18th May 20233:04 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSOxygen Finance secures six Early Payment contracts
15th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
28th Feb 20235:43 pmRNSHolding(s) in Company
23rd Jan 20237:00 amRNSStatement re Satago
20th Jan 20237:00 amRNSStatement regarding Satago and Trading Update
22nd Dec 20227:00 amRNSRejected Indicative Offer for Oxygen
15th Nov 20227:00 amRNSOxygen surpasses £1b in early payment provision
3rd Nov 20227:00 amRNSPlaystack releases new console game
20th Oct 20227:00 amRNSSatago signs agreement with Sage
10th Oct 20227:00 amRNSNotice of Capital Markets Day
30th Sep 20227:00 amRNSPDMR Notification
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Capital Markets Day
25th Aug 20229:37 amRNSHolding(s) in Company
29th Jul 20229:00 amRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSSatago signs commercial agreement with Lloyds
1st Jul 20227:00 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSSatago partnership with Sage and Lloyds
7th Jun 202211:19 amRNSResult of AGM
6th Jun 20227:00 amRNSStatement re Playstack
4th May 20225:58 pmRNSNotice of AGM
29th Apr 20227:00 amRNSFinal Results For The Year Ended 31 December 2021
19th Apr 202212:04 pmRNSHolding(s) in Company
12th Apr 20225:53 pmRNSHolding(s) in Company
11th Apr 202210:18 amRNSResult of GM and Result of Placing and Open Offer
23rd Mar 20227:00 amRNSResult of Placing and Notice of General Meeting
22nd Mar 20224:51 pmRNSProposed Placing and Open Offer
9th Mar 20227:00 amRNSStatement re Satago
22nd Feb 20222:04 pmRNSVesting of JSOP Founder Awards
16th Feb 20227:00 amRNSDirectorate Change and Relationship Agreement
10th Dec 20217:00 amRNSStatement regarding Satago and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.